.jpg?#)
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
What's Your Reaction?
